p34cdc2 in invasive breast cancer:: relationship to DNA content, Ki67 index and c-erbB-2 expression

被引:0
|
作者
Wiesener, B
Hauser-Kronberger, CE
Zipperer, E
Dietze, O
Menzel, C
Hacker, GW
机构
[1] Gen Hosp, St Johanns Spital, Inst Pathol Anat, A-5020 Salzburg, Austria
[2] Gen Hosp, St Johanns Spital, Dept Gynecol & Obstet, A-5020 Salzburg, Austria
关键词
c-erbB-2; DNA ploidy; invasive mammary carcinoma; Ki67; p34(cdc2);
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: One-hundred and eighty-eight cases of human mammary carcinoma were examined immunohistochemically for their expression of Ki67, p34(cdc2) and c-erbB-2. DNA image cytometry was performed to evaluate DNA ploidy, Auer type, S-phase fraction (SPF), 5c exceeding rate (5cER) and 2c deviation index (2cDI). Methods and results: One-hundred and sixty-eight cases were invasive ductal carcinomas, 20 were of invasive lobular type. Routinely assessed oestrogen and progesterone receptor scores were available, The results were analysed statistically in comparison to tumour type, histopathological grade, lymph node status, menopausal status, patient age and overall survival. Ki67 (P<0.002) and c-erbB-2 (P<0.0001) correlated well with overall survival (P<0.0008) and grade (P<0.038) but not: with lymph node status and tumour type. p34cdc2 showed a trend towards a positive correlation with Ki67 (P<0.058) and a significant negative correlation with receptor status (P<0.008) but with none of the other parameters examined. Conclusions: No association between the DNA measured parameters (Auer type, SPF, 5cER and 2cDI) and survival was found. Our results suggest that c-erbB-2 and Ki67 are parameters which might, in combination with receptor status, help to define subgroups with different outcomes.
引用
收藏
页码:522 / 530
页数:9
相关论文
共 50 条
  • [21] Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features
    Shpitz, B
    Bomstein, Y
    Sternberg, A
    Klein, E
    Tiomkin, V
    Kaufman, A
    Groisman, G
    Bernheim, J
    JOURNAL OF SURGICAL ONCOLOGY, 2002, 79 (02) : 86 - 92
  • [22] C-ERBB-2 EXPRESSION IN BREAST-CANCER DETECTED BY IMMUNOBLOTTING AND IMMUNOHISTOCHEMISTRY
    KERNS, BJM
    PENCE, JC
    HUPER, G
    KINNEY, RB
    IGLEHART, JD
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1990, 38 (12) : 1823 - 1830
  • [23] IMMUNOHISTOCHEMICAL STUDY ON THE EXPRESSION OF C-ERBB-2 ONCOPROTEIN IN BREAST-CANCER
    HORIGUCHI, J
    IINO, Y
    TAKEI, H
    YOKOE, T
    ISHIDA, T
    MORISHITA, Y
    ONCOLOGY, 1994, 51 (01) : 47 - 51
  • [24] No association between immunohistochemical expression of p53, c-erbB-2, Ki-67, estrogen and progesterone receptors in female papillary thyroid cancer and ionizing radiation
    Karlsson, MG
    Hardell, L
    Hallquist, A
    CANCER LETTERS, 1997, 120 (02) : 173 - 177
  • [25] Expression of COX-2, p16, and Ki67 in the range from normal breast tissue to breast cancer
    Feriancova, Michaela
    Walter, Ingrid
    Singer, Christian F.
    Gazdarica, Juraj
    Pohlodek, Kamil
    NEOPLASMA, 2021, 68 (02) : 342 - +
  • [26] Molecular markers (c-erbB-2, p53) in breast cancer
    Agrawal, Anil Kumar
    Jelen, Michal
    Rudnicki, Jerzy
    Grzebieniak, Zygmunt
    Zukrowski, Piotr
    Nienartowicz, Ewa
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2008, 46 (04) : 449 - 455
  • [27] Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
    Cheang, Maggie C. U.
    Chia, Stephen K.
    Voduc, David
    Gao, Dongxia
    Leung, Samuel
    Snider, Jacqueline
    Watson, Mark
    Davies, Sherri
    Bernard, Philip S.
    Parker, Joel S.
    Perou, Charles M.
    Ellis, Matthew J.
    Nielsen, Torsten O.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (10): : 736 - 750
  • [28] PROGNOSTIC-SIGNIFICANCE OF P53 AND C-ERBB-2 EXPRESSION IN OPERABLE BREAST-CANCER
    NOGUCHI, M
    KITAGAWA, H
    KINOSHITA, K
    MIYAZAKI, I
    SAITO, Y
    MIZUKAMI, Y
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1993, 2 (04) : 587 - 591
  • [29] Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer
    Nakopoulou, LL
    Alexiadou, A
    Theodoropoulos, GE
    Lazaris, AC
    Tzonou, A
    Keramopoulos, A
    JOURNAL OF PATHOLOGY, 1996, 179 (01) : 31 - 38
  • [30] The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer
    Gürel, S
    Dolar, E
    Yerci, Ö
    Samli, B
    Öztürk, H
    Nak, SG
    Gülten, M
    Memik, F
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1999, 27 (02) : 74 - 78